High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.
暂无分享,去创建一个
A. Nisalak | D. Vaughn | S. Kalayanarooj | S. Green | A. Rothman | F. Ennis | P. Young | T. Endy | D. Libraty | D. Pickering | S. Green
[1] V. Deubel,et al. Enzyme-Linked Immunosorbent Assay Specific to Dengue Virus Type 1 Nonstructural Protein NS1 Reveals Circulation of the Antigen in the Blood during the Acute Phase of Disease in Patients Experiencing Primary or Secondary Infections , 2002, Journal of Clinical Microbiology.
[2] D. Vaughn,et al. Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3' noncoding sequences. , 2001, Journal of virological methods.
[3] E. Chungue,et al. Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996–1997 dengue‐2 outbreak in French Polynesia , 2000, Journal of medical virology.
[4] P. Young,et al. An Antigen Capture Enzyme-Linked Immunosorbent Assay Reveals High Levels of the Dengue Virus Protein NS1 in the Sera of Infected Patients , 2000, Journal of Clinical Microbiology.
[5] A. Rothman,et al. Immunopathogenesis of Dengue hemorrhagic fever. , 1999, Virology.
[6] A. Nisalak,et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. , 1999, The Journal of infectious diseases.
[7] D. Kwiatkowski,et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. , 1998, The Journal of infectious diseases.
[8] A. Nisalak,et al. Early clinical and laboratory indicators of acute dengue illness. , 1997, The Journal of infectious diseases.
[9] A. Nisalak,et al. Dengue in the early febrile phase: viremia and antibody responses. , 1997, The Journal of infectious diseases.
[10] T. P. Monath. Dengue: the risk to developed and developing countries. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[11] V. Stollar,et al. Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. , 1989, Virology.
[12] A. Nisalak,et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. , 1989, The American journal of tropical medicine and hygiene.
[13] A. Nisalak,et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.
[14] G. Crane. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control , 1999 .
[15] A. Falconar,et al. The dengue virus nonstructural-1 protein (NS1) generatesantibodies to common epitopes on human blood clotting,integrin/adhesin proteins and binds to humanendothelial cells: potential implications in haemorrhagic fever pathogenesis , 1997, Archives of Virology.